IL6 and neoplasm: Our in vitro and in vivo experiments suggest that metabolic competition by glycolytic PDAC tumor cells leads to the accumulation of lactate in the TME and that CAFs utilize lactate to produce IL-6, which inhibits antitumor immunity.